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Abstract
The use of semantic technologies, such as ontologies, to describe and analyse biological systems is at the heart of systems biology.
Indeed, understanding the behaviour of cells requires a large amount of context information. In this paper, we propose an ontology
entitled ”Biomolecular Network ontology” using the OWL language. The BNO ontology standardises the terminology used by
biologists experts to address issues including semantic behaviour representation, reasoning and knowledge sharing. The main
benefit of this proposed ontology is the ability to reason about dynamical behaviour of complex biomolecular networks over time.
We demonstrate our proposed ontology with a detailed example, the bacteriophage T4 gene 32 use case.
c 2017 The Authors. Published by Elsevier B.V.
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1. Introduction
To understand how our body works it is extremely crucial to focus on the behaviour of the cells and how cells
correctly respond to their environments. Indeed, cells are exposed to several environmental stimuli. These detectable
change in the cell’s environment can be internal such as the increased concentration of intracellular components, or
external effects such as the ones of taking medication. In general, cell adaptation to these stimuli refers to changes
in the state of the cell molecular components. These molecular components interact together creating a complex
biomolecular network that consists of a set of nodes, denoting the molecular components and a set of edges, denoting
the interactions among these cellular components. These networks are considered as systems that dynamically evolve
from a state to another so that the cell can adapt itself to changes in its environment. This issue has already been
addressed in Wu et al. ’s research1, where they introduce and define the transittability of biomolecular networks as
their steering from an undesired state to a desired state1.
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Our research team has already proposed a platform to simulate the state changes in complex biomolecular net-
works2. Our approach is based on semantic technologies. Moreover, intense research in molecular biology has led
to major discoveries in cellular components, producing accumulation of a large volume of knowledge about these
components. It would therefore be helpful to exploit this knowledge to increase the understanding the behaviour of
complex biomolecular networks. In fact, ontologies with their clearly-defined and well-structured descriptions are
vital tools for the effective application of ‘omic’ information through computational approaches.
Our previous works3 propose a semantic architecture for modelling the behaviour of complex biomolecular net-
works over time. This semantic architecture is based on four ontologies: the Gene Ontology (GO)1, the Simple Event
Model Ontology (SEMO)2, the Time Ontology (TO)3 and our development, the Biomolecular Network Ontology
(BNO). This semantic approach aims at enriching the structural description of biomolecular networks by contextual
knowledge concerning their state transitions, the events that can steer these transitions and the complete temporal
context linked to this information.
In this article, we detail and describe the Biomolecular Network Ontology, that aims at giving a formal and semantic
representation that models all the necessary biological knowledge to study and reason on complex biomolecular net-
works. This semantic representation wishes to meet the following goals: (1) Determine the structure of a biomolecular
network by identifying its heterogeneous components and the relations among them; (2) Define the specific functions
of all molecules and the different nature of interactions they provide; (3) Understand how a cell works through the
semantic interpretation of knowledge involved in the network’s behaviour; (4) Perturb the network with stimuli by
changing the concentration of an element and observe its behaviour; (5) Reasoning and inferring new knowledge; (6)
Simulate and identify the different states of the biomolecular network over time.
The presentation of this work is structured as follows. Section 2 reviews the necessary preliminaries from complex
biomolecular networks and ontologies, and presents a brief state of the art on the existing ontologies in systems
biology. Section 3 describes our proposed biomolecular network ontology in more detail. Section 4 provides a case
study to demonstrate how the proposed ontology can be used for reasoning on the bacteriophage T4 gene 32 whereas
concluding remarks are in Section 5.
2. Background and related work
In this section, we describe approaches close to our works. Especially, we discuss those that use ontologies and
semantic information to enable and improve understanding of cells.
2.1. Complex Biomolecular Networks
The cell is a complex system consisting of thousands of diverse molecular entities (genes, proteins and metabo-
lites) which interact with each other physically, functionally and logically creating a biomolecular network1,4. The
complexity of the biomolecular network appears by its decomposition into three levels: the genome level models
the genetic material of an organism, the proteome level describes the entire set of proteins and the metabolism level
contains the complete set of small-molecule chemicals5. Depending on the type of their cellular components and
their interactions, we can distinguish the three basic types of networks: the Gene Regulatory networks (GRNs), the
Protein-Protein-Interaction networks (PPINs) and the Metabolic networks (MNs), that were logically and semantically
formalized in our previous works2,3.
2.2. Ontologies in systems biology
The use of ontological reasoning for interoperable data management is an increasingly accepted method in the field
of systems biology research6. Indeed, over the past decades has emerged an incredible amount of ontologies in the
1 http://www.geneontology.org
2 http://semanticweb.cs.vu.nl/2009/11/sem/
3 https://www.w3.org/TR/owl-time/
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3 https://www.w3.org/TR/owl-time/
526 Ali Ayadi et al. / Procedia Computer Science 112 (2017) 524–533
Ali Ayadi et al. / Procedia Computer Science 00 (2017) 000–000 3
Open Biological and Biomedical Ontologies (OBO) Foundry4 which provides a large variety of bio-ontologies and
the BioPortal5 web application of the National Center for Biomedical Ontology (NCBO) which provides access to
more than 600 biomedical ontologies7. By the exploration of these bio-ontologies via browsers such the Ontology
Lookup Service6, it may be concluded that these ontologies treat different parts of systems biology such as cell
types8,9, the molecular functions10, the diseases11, bioinformatics software, experimental data analysis12, etc. All
these bio-ontologies differ in the type of knowledge they describe, their intended purpose and their level of abstraction.
Although there are several promising bio-ontologies in the systems biology domain, until now and to the best of
our knowledge, there is no ontology for modeling the behaviour of complex biomolecular networks. In fact, very few
researches use ontologies for defining the possible biological functions, like signal transducer activity in the case of
the GO10, or the cell behaviour ontology13 which describes and focuses on cell and tissue biology.
As was discussed, current ontologies for the systems biology domain do not focus on the description of the
biomolecular network’s transittability. In fact, there is a lack of standard representation of entities which take part
in the analysis the behaviour of complex biomolecular networks and of the relations among them. As will be shown in
the following sections, these entities are complex and have several relations among them. So, developing an ontology
to formally define in a formal way this concrete domain is more than evident. Therefore, in this paper, a new ontology
for the representation of this domain is proposed.
3. Description of the biomolecular network ontology
In this section, we describe our ontology for understanding the behaviour of complex biomolecular networks and
their transittability. As described in Figure 1, we code and simulate the BNO ontology using OWL-language14 using
prote´ge´ editor7, version 5.2.0.
3.1. The key classes
We define five main classes namely BNO : Biomolecular Network, BNO : Node, BNO : Interaction, NodeState
and BNO : Type Interaction. The BNO : Biomolecular Network class has been further divided into the three types of
networks: the BNO : Genomic Network, BNO : Proteomic Network and BNO : Metabolomic Network (as detailed
in Section 2.1). The instances of these classes will be defined later, among these instances we will focus on the
BacteriophageT4G32 instance in Section 4. The BNO : Node class is the super-class of the three types of nodes:
the BNO : Gene which is itself divided into two types the BNO : DNA and BNO : RNA, the BNO : Protein and the
BNO :Metabolite. The Interaction class contains a list of all the interactions among the different types of nodes as
its subclasses. The NodeState class consists of two subclasses ActivationState and ConcentrationState. Finally, the
BNO : Type Interaction class contain a list of all the types of interactions, the instances of this class belong to the set
of concepts of the Interaction Ontology proposed by Van Landeghem et al.15. Figure 1 and Table 1 show the most
important BNO classes.
3.2. The major properties and data types
After the definition of the major BNO concepts and in order to describe the semantic relations among them, we
need to define the domain, range, property type and inverse properties as constraint conditions. Table 2 summarises
of the major properties, including their domain, range and inverse.
4 http://www.obofoundry.org/
5 http://bioportal.bioontology.org/
6 http://www.ebi.ac.uk/ols/index
7 http://protege.stanford.edu/
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Fig. 1. The Biomolecular Network Ontology: hierarchy of classes, hierarchy of properties and hierarchy of data properties.
4. Application of BNO
The aim of this section is to illustrate the proposed BNO ontology for reasoning and inferring new knowledge with
sets of rules expressed in SWRL14.
4.1. Example of the bacteriophage T4 gene 32 use case
We test the performance of the proposed BNO ontology by using a real example of a biomolecular network, the
bacteriophage T4 gene 3216. As described in Figure 2, this biomolecular network consists of three nodes a gene
G32 coding for a protein p32 and a metabolite m32 which can catalyse the protein p32. In this network, the
concentration of p32 is regulated by itself and normally should remain between 0.2 10−6 Mol and 0.7 10−6 Mol.
When the concentration of p32 exceeds the threshold Sp32 = 0.7 10−6 Mol, we talk about an Inhibition in which
the protein p32 inhibits the translation of its gene G32 making it deactivated. However, when the concentration of
p32 decreases and becomes lower than the threshold Sp32 = 0.2 10−6 Mol, we talk about an Activation in which the
protein p32 activates the translation of its geneG32 making it activated. When the geneG32 is activated by the protein
p32, we talk about a Translation in which we have a production of p32 by increasing the value of its concentration.
When the concentration of m32 exceeds the threshold Sm32 = 0.8 10−6 Mol, the metabolite m32 catalyses the p32 by
decreasing the value of its concentration, here we treat a Catalysis.
4.2. Instantiation of the BNO ontology for the given example
Figure 3 presents the instantiation of the BNO ontology for the given example of the bacteriophage T4 gene 32.
The BNO ontology provides detailed and rigorous semantics to model this biomolecular network. We use the Prote´ge´
editor to instantiate the BNO ontology for the bacteriophage T4 gene 32. Figure 4 illustrates the nodes instantiations
respectively, the gene G32, protein p32 and metabolite m32. The instantiations of the four reactions are detailed in
Figure 5.
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Table 1. A summary of classes in the Biomolecular Network ontology.The left column presents the five major classes and their immediate sub-
classes. The right column presents the description of these classes.
BNO ontology classes Description
BNO:BiomolecularNetwork It defines the different kinds of complex biomolecular networks.
BNO:GenomicNetwork It defines the interactions among genes forming Gene Regulatory networks.
BNO:ProteomicNetwork It defines the interactions among proteins forming Protein-Protein Interaction networks.
BNO:MetabolomicNetwork It defines the interactions among proteins forming Metabolic networks.
BNO:Node It defines the different types of cellular entities.
BNO:Gene It describes the set of genes MG.
BNO:DNA It describes the set DNA.
BNO:RNA It describes the set of RNA.
BNO:Protein It describes the set proteins MP.
BNO:Metabolite It describes the set metabolites MM .
BNO:Interaction It defines all the types of interactions operated among the nodes.
BNO:IntraomicInteraction It defines the interactions between molecular components of the same type.
BNO:I GG It defines the interactions between genes.
BNO:I PP It defines the interactions between proteins.
BNO:I MM It defines the interactions between metabolites.
BNO:InteromicInteraction It defines the interactions between molecular components of the different type.
BNO:I GP It defines the interactions between genes and proteins.
BNO:I PG It defines the interactions between proteins and genes.
BNO:I PM It defines the interactions between proteins and metabolites.
BNO:I MP It defines the interactions between metabolites and proteins.
BNO:NodeState It defines the possible states of the nodes.
BNO:ActivationState It defines the states of the genes.
BNO:ConcentrationState It defines the concentration of the proteins and metabolites.
BNO:InteractionType It defines the nature of the interaction among cellular components.
Table 2. A summary of the properties, including their domain, range and inverse.
BNO ontology properties Domain Range Inverse
hasBehaviour BiomolecularNetwork Behaviour isBehaviourOf
hasInteraction BiomolecularNetwork Interaction isInteractionOf
hasNode BiomolecularNetwork Node isNodeOf
hasSource BiomolecularNetwork Node isSourceOf
hasEnd Interaction Node isEndOf
hasState Interaction State isStateOf
hasTypeInteraction Interaction TypeInteraction isTypeInteractionOf
4.3. Reasoning with SWRL rules
The Semantic Web Rule Language (SWRL) is an ontological language based on OWL-DL and OWL-Lite that
to express the rule description language based on OWL17. SWRL can be used to write rules to reason about OWL
individuals and to infer new knowledge about those individuals. The rules in SWRL are implication rules, and follow
this syntax: antecedent → consequent. This form means that the consequent must be true when the antecedent is
satisfied. In the SWRL rules, the symbol ∧ means conjunction, ?x is a variable, → means implication. A symbol
without the leading ’?’ denotes the name of an instance (an individual) in the ontology. These SWRL rules can
provide additional expressiveness to OWL-based ontologies. Thus we adopt these SWRL rules to build the reasoning
rules in order to represent the dynamic aspect of the biomolecular network. During this reasoning, inferences are
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Fig. 2. Instantiation of the BNO ontology for the given example.
Fig. 3. Instantiation of the BNO ontology for the given example.
Fig. 4. A snapshot look at the BNO node instances associated with the given example displaying respectively: (1) the gene G32, (2) the protein
p32 and (3) the metabolite m32.
made, classifying the instances of the BNO ontology and associating new properties to instances while maintaining
logical consistency.
4.3.1. Inhibition SWRL rule
The following rule models the inhibition reaction. When the concentration of the protein p32 exceeds the threshold
0.7 10−6, it inhibits the translation of its gene G32.
ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ hasState(?g, ?gs2) ∧ forTime(?gs2, ?t2) ∧
swrlb:add(?t2, ?t, 1) ∧ Protein(?p) ∧ Activation(?activ) ∧ hasSource(?activ, ?p) ∧ hasEnd(?activ,
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Fig. 5. A snapshot look at the BNO interaction instances associated with the given example displaying respectively: (1) Activation, (2) Inhibition,
(3) Transcription and (4) Catalysis.
?g)∧ hasState(?p, ?ps)∧ forTime(?ps, ?t)∧ hasConcentrationValue(?ps, ?c)∧ swrlb:greaterThanOrEqual(?c,
0.7)→ isActivated(?gs2, false)
As depicted in Figure 6, the results of this rule means that, If there is a gene g having a state gs equal to false at a
given time t and there is a protein p having a state ps1 and a concentration c at this time t, and these two molecules
g and p are related by an Activation interaction, and if the concentration of p is under a threshold equal to 0.2, then
the state of g move to true at time t+1.
4.3.2. Activation SWRL rule
In contrast to the first rule, this rule models the activation reaction. When the concentration of the protein p32
becomes less than the threshold 0.2 10−6, it activates the translation of the Gene G32.
ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ hasState(?g, ?gs2) ∧ forTime(?gs2, ?t2) ∧
swrlb:add(?t2, ?t, 1) ∧ Protein(?p) ∧ Activation(?activ) ∧ hasSource(?activ, ?p) ∧ hasEnd(?activ,
?g)∧ hasState(?p, ?ps)∧ forTime(?ps, ?t)∧ hasConcentrationValue(?ps, ?c)∧ swrlb:lessThanOrEqual(?c,
0.2)→ isActivated(?gs2, true)
As described in Figure 7, the results of this rule means that, If there is a gene g having a state gs equal to true at a
given time t and there is a protein p having a state ps1 and a concentration c at this time t, and these two molecules g
and p are related by an Inhibition interaction, and if the concentration of p exceeds a threshold equal to 0.7, then the
state of g move to false at time t+1.
4.3.3. Transcription SWRL rule
The following rule represents the gene transcription. In fact, if the gene G32 is activated, this one generates the
protein synthesis and produces an increase in the concentration of this protein p32.
ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ isActivated(?gs1, false) ∧ Protein(?p) ∧ Tran-
scription(?trans)∧ hasSource(?trans, ?g)∧ hasEnd(?trans, ?p)∧ hasState(?p, ?ps1)∧ forTime(?ps1,
?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧ forTime(?ps2, ?t2) ∧ swrlb:add(?t2,
?t, 1)→ hasConcentrationValue(?ps2, ?c1)
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Fig. 6. Results of the reasoning process for the Inhibition SWRL rule.
Fig. 7. Results of the reasoning process for the Activation SWRL rule.
The result of this rule is interpreted as, If there is a gene g having a state gs equal to true at a given time t and there
is a protein p having a state ps1 and a concentration c at this time t, and these two molecules g and p are related by
a Transcription interaction, then the concentration of the protein p increases at time t+1.
In the opposite case, we have this rule:
ADN(?g) ∧ hasState(?g, ?gs1) ∧ forTime(?gs1, ?t) ∧ isActivated(?gs1, false) ∧ Protein(?p) ∧ Tran-
scription(?trans)∧ hasSource(?trans, ?g)∧ hasEnd(?trans, ?p)∧ hasState(?p, ?ps1)∧ forTime(?ps1,
?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧ forTime(?ps2, ?t2) ∧ swrlb:add(?t2,
?t, 1)→ hasConcentrationValue(?ps2, ?c1)
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The result of this rule means: If there is a gene g having a state gs equal to false at a given time t and there is a
protein p having a state ps1 and a concentration c at this time t, and these two molecules g and p are related by a
Transcription interaction, then the concentration of the protein p remains stable at time t+1.
4.3.4. Catalysis SWRL rule
As well, following the increase of the concentration of the protein p32, a catalysis reaction resulted to create
hormone balance. This reaction is ensured by the following rule:
Metabolite(?m) ∧ hasState(?m, ?ms) ∧ hasConcentrationValue(?ms, ?c) ∧ forTime(?ms, ?t) ∧ Pro-
tein(?p) ∧ Catalysis(?cat) ∧ hasSource(?cat, ?m) ∧ hasEnd(?cat, ?p) ∧ deltaC(?cat, ?delta) ∧ has-
State(?p, ?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧ for-
Time(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) ∧ swrlb:greaterThanOrEqual(?c, 0.8) ∧ swrlb:subtract(?c2,
?c1, ?delta)→ hasConcentrationValue(?ps2, ?c2)
The meaning f this rule is: If there is a metabolite m having a state ms associated to a concentration value c at a given
time t and there is a protein p having a state ps1 and a concentration c1 at this time t, and these two molecules g
and p are related by a Catalysis interaction, and if the concentration of m exceeds a threshold equal to 0.8, then the
concentration of the protein p decreases at time t+1.
In contrast, when the concentration of the metabolite m32 is less than 0.8 we applied the following rule:
Metabolite(?m) ∧ hasState(?m, ?ms) ∧ hasConcentrationValue(?ms, ?c) ∧ forTime(?ms, ?t) ∧ Pro-
tein(?p) ∧ Catalysis(?cat) ∧ hasSource(?cat, ?m) ∧ hasEnd(?cat, ?p) ∧ deltaC(?cat, ?delta) ∧ has-
State(?p, ?ps1) ∧ forTime(?ps1, ?t) ∧ hasConcentrationValue(?ps1, ?c1) ∧ hasState(?p, ?ps2) ∧ for-
Time(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) ∧ swrlb:lessThan(?c, 0.8) → hasConcentrationValue(?ps2,
?c1)
Which means: If there is a metabolite m having a state ms associated to a concentration value c at a given time
t and there is a protein p having a state ps1 and a concentration c1 at this time t, and these two molecules g and
p are related by a Catalysis interaction, and if the concentration of m is under a threshold equal to 0.8, then the
concentration of the protein p remains stable at time t+1.
4.4. Evaluation
The verification of the logical axioms is an essential task in ontology evaluation. Indeed, this evaluation ensures
that the logical axioms are satisfiable and consistent. This satisfaction consists in: (i) checking the encoding of the
specification; (ii) detecting errors such as: class hierarchies, redundant axioms, etc.; (iii) confirming that the BNO
ontology has been built according to certain specified ontology quality criteria. This consistency was ensured by
the SWRL rules reasoning discussed in the previous section which must be evaluated by biologists experts. That is
why we obtained the assistance and expertise of our colleagues from the CSTB (Complex Systems and Translational
Bioinformatics) team who have evaluated the BNO ontology and conclude that it is in accordance with their expert
knowledge about the domain. Moreover, this consistency was approved by the results of our experiments as shown in
Figures 6 and 7.
In addition to the evaluation conducted by biologists, we adopted a qualitative evaluation method following the
validation protocol proposed by d’Aquin et al. 18. This validation protocol is essentially based on a number of criteria
that will enable us to determine whether our ontology is relevant or not. These evaluation criteria focus on: (1) the
accuracy, which is one of the most important criteria to be met by the ontology classes. (2) The size that represents
the number of classes, properties, and individuals that an ontology contains. This is one of the most relevant indicators
to assess the effectiveness of an ontology. This size determines whether the ontology sufficiently covers the domain
that interests us. (3) The cohesion which makes it possible to determine the degree of connectivity between the
different instances present in the same class. This metric makes it possible to evaluate the number of root classes
in the ontology’s hierarchy, the number of properties per class, and the longest depth of inheritance of concepts of
the ontology. (4) The coverage of the domain which is a criterion for assessing the degree of representativeness of a
domain of application by a specific class. This criterion makes it possible to determine the ontology’s ability to cover
and represent exactly the domain of application in question.
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5. Discussion and concluding remarks
This paper has presented an ontology of complex biomolecular networks behaviour aimed at assisting biologists
by providing them sufficient contextual detail for understanding the dynamical behaviour of complex biomolecular
networks over time. We developed the BNO ontology from experiences of domain experts biologists to describe the
domain of complex biomolecular networks. This ontology provides information on the biomolecular network and its
components (nodes, interactions, states, transition states, etc.) and an indication of the network’s context such as: the
type of the sub-network, the type of the node, the conditions of the interactions, the nature of the interaction, etc. This
allows to precisely explain and interpret the semantic context in order to achieve intelligent modelling of biomolecular
networks and their state changes. All these state changes can be carried out by a rule-based system.
We have experimented these rules on a small biomolecular network but this example is significant and contains
all the constraints that are used. This case study with OWL-SWRL rules represents a ”proof of concept” since it
demonstrates the logical consistency of the proposed BNO ontology and check its relevance. To check the inconsis-
tencies and violations of these SWRL rules, we used the latest version of HermiT reasoning plugin in the Prote´ge´
5 environment 8 version 1.3.8.3. Results prove that our ontology can be successfully integrated into the rest of our
project presented in Section 1. However we must emphasise that, even if this ontology provides useful knowledge and
rich semantics allowing biologists to understand dynamical behaviour of complex biomolecular networks, it can not
simulate large-scale networks. That is why more efficient simulation tools should be used for scaling up and reason
on large biomolecular networks.
For further research, we aim to: (1) complete the current version of the BNO ontology and mapping it with other
ontologies such as the Gene Ontology, and to (2) consider the complexity of complex biomolecular networks and to
simulate large networks by using discrete time simulation tools.
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The result of this rule means: If there is a gene g having a state gs equal to false at a given time t and there is a
protein p having a state ps1 and a concentration c at this time t, and these two molecules g and p are related by a
Transcription interaction, then the concentration of the protein p remains stable at time t+1.
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Time(?ps2, ?t2) ∧ swrlb:add(?t2, ?t, 1) ∧ swrlb:greaterThanOrEqual(?c, 0.8) ∧ swrlb:subtract(?c2,
?c1, ?delta)→ hasConcentrationValue(?ps2, ?c2)
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time t and there is a protein p having a state ps1 and a concentration c1 at this time t, and these two molecules g
and p are related by a Catalysis interaction, and if the concentration of m exceeds a threshold equal to 0.8, then the
concentration of the protein p decreases at time t+1.
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to assess the effectiveness of an ontology. This size determines whether the ontology sufficiently covers the domain
that interests us. (3) The cohesion which makes it possible to determine the degree of connectivity between the
different instances present in the same class. This metric makes it possible to evaluate the number of root classes
in the ontology’s hierarchy, the number of properties per class, and the longest depth of inheritance of concepts of
the ontology. (4) The coverage of the domain which is a criterion for assessing the degree of representativeness of a
domain of application by a specific class. This criterion makes it possible to determine the ontology’s ability to cover
and represent exactly the domain of application in question.
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5. Discussion and concluding remarks
This paper has presented an ontology of complex biomolecular networks behaviour aimed at assisting biologists
by providing them sufficient contextual detail for understanding the dynamical behaviour of complex biomolecular
networks over time. We developed the BNO ontology from experiences of domain experts biologists to describe the
domain of complex biomolecular networks. This ontology provides information on the biomolecular network and its
components (nodes, interactions, states, transition states, etc.) and an indication of the network’s context such as: the
type of the sub-network, the type of the node, the conditions of the interactions, the nature of the interaction, etc. This
allows to precisely explain and interpret the semantic context in order to achieve intelligent modelling of biomolecular
networks and their state changes. All these state changes can be carried out by a rule-based system.
We have experimented these rules on a small biomolecular network but this example is significant and contains
all the constraints that are used. This case study with OWL-SWRL rules represents a ”proof of concept” since it
demonstrates the logical consistency of the proposed BNO ontology and check its relevance. To check the inconsis-
tencies and violations of these SWRL rules, we used the latest version of HermiT reasoning plugin in the Prote´ge´
5 environment 8 version 1.3.8.3. Results prove that our ontology can be successfully integrated into the rest of our
project presented in Section 1. However we must emphasise that, even if this ontology provides useful knowledge and
rich semantics allowing biologists to understand dynamical behaviour of complex biomolecular networks, it can not
simulate large-scale networks. That is why more efficient simulation tools should be used for scaling up and reason
on large biomolecular networks.
For further research, we aim to: (1) complete the current version of the BNO ontology and mapping it with other
ontologies such as the Gene Ontology, and to (2) consider the complexity of complex biomolecular networks and to
simulate large networks by using discrete time simulation tools.
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